Michael Nyberg
Overview
Explore the profile of Michael Nyberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bleckwehl T, Babler A, Tebens M, Maryam S, Nyberg M, Bosteen M, et al.
Nat Cardiovasc Res
. 2024 Dec;
4(1):26-44.
PMID: 39715784
Atherosclerosis is a pervasive contributor to ischemic heart disease and stroke. Despite the advance of lipid-lowering therapies and anti-hypertensive agents, the residual risk of an atherosclerotic event remains high, and...
2.
Gill D, Dib M, Cronje H, Karhunen V, Woolf B, Gagnon E, et al.
BMC Med
. 2024 Oct;
22(1):473.
PMID: 39407214
Background: Drug target Mendelian randomization describes the use of genetic variants as instrumental variables for studying the effects of pharmacological agents. The paradigm can be used to inform on all...
3.
Madsen P, Sejersen C, Nyberg M, Sorensen M, Hellsten Y, Gaede P, et al.
Front Physiol
. 2024 Apr;
15:1294369.
PMID: 38571722
The significant morbidity and premature mortality of type 2 diabetes mellitus (T2DM) is largely associated with its cardiovascular consequences. Focus has long been on the arterial atheromatosis of DM giving...
4.
Bachmann J, Kirchhoff J, Napolitano J, Sorota S, Gordon W, Feric N, et al.
Exp Physiol
. 2023 Jul;
108(9):1172-1188.
PMID: 37493451
The role of C-type natriuretic peptide (CNP) in the regulation of cardiac function in humans remains to be established as previous investigations have been confined to animal model systems. Here,...
5.
Cronje H, Karhunen V, Hovingh G, Coppieters K, Lagerstedt J, Nyberg M, et al.
BMC Med
. 2023 Apr;
21(1):158.
PMID: 37101178
Background: C-type natriuretic peptide (CNP) is a known target for promoting growth and has been implicated as a therapeutic opportunity for the prevention and treatment of cardiovascular disease (CVD). This...
6.
Punjabi M, Kosareva A, Xu L, Ochoa-Espinosa A, Decembrini S, Hofmann G, et al.
JACC Basic Transl Sci
. 2023 Mar;
8(2):189-200.
PMID: 36908664
The authors determined the effect of the GLP-1 receptor agonist liraglutide on endothelial surface expression of vascular cell adhesion molecule (VCAM)-1 in murine apolipoprotein E knockout atherosclerosis. Contrast-enhanced ultrasound molecular...
7.
Jensen D, Skovsted G, Bonde M, Bentzon J, Rolin B, Franck G, et al.
Atheroscler Plus
. 2023 Jan;
49:32-41.
PMID: 36644202
Background And Aims: Randomized clinical studies have shown a reduction in cardiovascular outcomes with glucagon-like peptide 1 receptor agonist (GLP-1RA) treatment with the hypothesized mechanisms being an underlying effect on...
8.
Nyberg M, Terzic D, Ludvigsen T, Mark P, Michaelsen N, Abildstrom S, et al.
Endocr Rev
. 2022 Nov;
44(3):379-392.
PMID: 36346821
Measurement of natriuretic peptides (NPs) has proven its clinical value as biomarker, especially in the context of heart failure (HF). In contrast, a state of partial NP deficiency appears integral...
9.
Suur B, Chemaly M, Lindquist Liljeqvist M, Djordjevic D, Stenemo M, Bergman O, et al.
Front Pharmacol
. 2022 Oct;
13:988561.
PMID: 36188622
Proprotein convertase subtilisin/kexins (PCSKs) constitute a family of nine related proteases: PCSK1-7, MBTPS1, and PCSK9. Apart from PCSK9, little is known about PCSKs in cardiovascular disease. Here, we aimed to...
10.
Nyberg M, Jones A
Front Physiol
. 2022 Jul;
13:898395.
PMID: 35774284
Skeletal muscle is one of the most dynamic metabolic organs as evidenced by increases in metabolic rate of >150-fold from rest to maximal contractile activity. Because of limited intracellular stores...